Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Hydroxyapatite (MCHC) vs Iron: Iron has the stronger overall evidence (9 vs 4.5/10); they work on different things and are often used together, not either/or. Take the 60-second quiz for a pick tailored to your goals.
Iron wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Likely helps
6 of 8 studies with measurable effects showed benefit.
Top outcomes
3,320 mg of the compound daily, as two 830 mg tablets twice a day (about 712 mg elemental calcium), the regimen of the 3-year osteoporosis trial and the 851-woman cohort. A 6-month pain trial used 1,660 mg a day.
Split doses with meals, Morning and evening
Ossein-hydroxyapatite compound tablets
18-40mg elemental iron for deficiency (varies by severity) (a typical label dose, not the dose used in the cited trials, which used 60 to 120 mg a day)
On empty stomach if tolerated, Away from tea, coffee, dairy
Ferrous bisglycinate (gentle, well-absorbed) or iron protein succinylate
and 7 more not shown
and 6 more not shown
In single-meal studies 300-600 mg calcium reduced iron absorption by 50-60%. Long-term studies of raised calcium intake show no change in iron status, so the effect matters most for people treating iron deficiency.
Separate by 2+ hours. Take iron away from hydroxyapatite and other calcium products, ideally with vitamin C.
12-36 months
N/A
Hours to 3 months
5-6 months
2-4 weeks
4-8 weeks
4-12 weeks
Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis.
Menopause (2009) · Meta analysis
Meta-analysis of randomised controlled trials comparing ossein-hydroxyapatite complex (OHC) with calcium carbonate, not with placebo. Of 18 controlled trials identified, 6 were pooled in a random-effects model, and the abstract does not give the total number of participants.
Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females.
Osteoporos Int (1995) · Rct · n=40
Randomised, double-masked trial in 40 women with postmenopausal osteoporosis, each given 1,400 mg calcium a day as either OHC or calcium carbonate for 20 months.
Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.
Clin Drug Investig (2011) · Rct · n=120
Randomised, open-label trial in 120 women over 65 with osteoporosis (55 OHC, 65 calcium carbonate), of whom 54 completed 3 years. OHC gave 712 mg elemental calcium a day and calcium carbonate 1,000 mg, and both groups also took calcifediol.
Daily oral iron supplementation during pregnancy
The Cochrane database of systematic reviews (2024) · Meta analysis · n=48971
There is probably little to no difference in maternal death (2 versus 4 events, RR 0.57, 95% CI 0.12 to 2.69; 3 trials, 14,060 women; moderate-certainty evidence).
The Prevalence of Anemia among Pregnant Women in China: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta analysis · n=1376204
The results showed that the prevalence of anemia, ID, and IDA among pregnant women in China were 30.7% (95% CI: 26.6%, 34.7%), 45.6% (95% CI: 37.0%, 54.2%), and 17.3% (95% CI: 13.9%, 20.7%), respectively.
Treatment for women with postpartum iron deficiency anaemia
The Cochrane database of systematic reviews (2024) · Meta analysis · n=4558
Intravenous iron versus oral iron supplementation The evidence is very uncertain about the effect of intravenous iron on mortality (risk ratio (RR) 2.95, 95% confidence interval (CI) 0.12 to 71.96; P = 0.51; I² = not applicable; 3 RCTs; 1 event; 572 women; very low-certainty evidence).
Iron has a higher evidence score (9/10 vs 4.5/10) and wins in 2 of 3 categories.
In single-meal studies 300-600 mg calcium reduced iron absorption by 50-60%. Long-term studies of raised calcium intake show no change in iron status, so the effect matters most for people treating iron deficiency. Separate by 2+ hours. Take iron away from hydroxyapatite and other calcium products, ideally with vitamin C. Consult a healthcare provider for personalized advice.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Tired? Why most "energy" pills only work if they fix a deficit — and how to find yours first.
Selenium helps; iodine can WORSEN Hashimoto’s. The honest take on "thyroid support".
What’s safe while nursing, the truth about milk-supply herbs, and what to avoid (it passes into milk).
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.